Cargando…

Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer

Breast cancer is the second most common cancer among women in the United States in which the standard of care treatment is surgery with adjunctive therapy. Cryoablation, which destroys the tumor using extremely cold temperatures while preserving the potential tumor antigens, is a promising alternati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sardela de Miranda, Flávia, Castro, Maribel, Remmert, Nicole, Singh, Sharda P., Layeequr Rahman, Rakhshanda, Melkus, Michael W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582696/ https://www.ncbi.nlm.nih.gov/pubmed/37860001 http://dx.doi.org/10.3389/fimmu.2023.1258873

Ejemplares similares

ASO Author Reflections: Achieving Surgical De-Escalation of Breast Cancer Through Cryoablation
por: Melkus, Michael W., et al.
Publicado: (2023)

Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients
por: Khan, Sonia Y., et al.
Publicado: (2023)

Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer: A Pilot Study
por: Khan, Sonia Y., et al.
Publicado: (2022)

Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular Carcinoma
por: Li, Xin, et al.
Publicado: (2021)

Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study
por: Wei, Fuqun, et al.
Publicado: (2022)

Chemoprevention of Breast Cancer: The Paradox of Evidence versus Advocacy Inaction
por: Rahman, Rakhshanda Layeequr, et al.
Publicado: (2012)

Progress in the cryoablation and cryoimmunotherapy for tumor
por: Chen, Zenan, et al.
Publicado: (2023)

Sociodemographic Determinants in Breast Cancer Screening among Uninsured Women of West Texas
por: Jensen, Brooke, et al.
Publicado: (2022)

Sociodemographic Determinants in Cervical Cancer Screening Among the Underserved West Texas Women
por: Jensen, Brooke, et al.
Publicado: (2023)

Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer
por: Boissière-Michot, Florence, et al.
Publicado: (2022)

PD-1/PD-L1 immune checkpoint inhibitors in metastatic triple-negative breast cancer: a systematic review and meta-analysis
por: Yu, Yinan, et al.
Publicado: (2023)

Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors
por: Yakkala, Chakradhar, et al.
Publicado: (2019)

An update on the use of cryoablation and immunotherapy for breast cancer
por: Olagunju, Akindele, et al.
Publicado: (2022)

Dishevelled 2 regulates cancer cell proliferation and T cell mediated immunity in HER2-positive breast cancer
por: Rasha, Fahmida, et al.
Publicado: (2023)

Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade
por: Hübbe, Mie Linder, et al.
Publicado: (2020)

Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
por: Heeke, Arielle L., et al.
Publicado: (2021)

Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors
por: Abdou, Yara, et al.
Publicado: (2022)

Cryoablation and immune synergistic effect for lung cancer: A review
por: Tian, Yulong, et al.
Publicado: (2022)

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment
por: Zhang, Jinguo, et al.
Publicado: (2023)

Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy
por: Mirandola, Leonardo, et al.
Publicado: (2017)

PD-L1 expression as biomarker of efficacy of PD-1/PD-L1 checkpoint inhibitors in metastatic triple negative breast cancer: A systematic review and meta-analysis
por: Khan, Muhammad, et al.
Publicado: (2023)

Rate of Freeze Impacts the Survival and Immune Responses Post Cryoablation of Melanoma
por: Yakkala, Chakradhar, et al.
Publicado: (2021)

Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells
por: Juliá, Estefanía Paula, et al.
Publicado: (2018)

Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer
por: Tan, Abel H. Y., et al.
Publicado: (2019)

Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity
por: Wu, Ying, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker
por: Qureshi, Sadaf, et al.
Publicado: (2022)

Pan-Cancer Analysis Identifies Liver Metastases as Negative Predictive Factor for Immune Checkpoint Inhibitors Treatment Outcome
por: Chen, Xiao-Juan, et al.
Publicado: (2021)

Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
por: Menikdiwela, Kalhara R., et al.
Publicado: (2022)

Comprehensive Profiling of Cancer-Associated Cells in the Blood of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy to Predict Pathological Complete Response
por: Pore, Adity A., et al.
Publicado: (2023)

Cryoablation and immunity in non-small cell lung cancer: a new era of cryo-immunotherapy
por: Velez, Antonio, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
por: Thomas, Remy, et al.
Publicado: (2021)

Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis
por: Westdorp, Harm, et al.
Publicado: (2021)

Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
por: von Knethen, Andreas, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
por: Ghouzlani, Amina, et al.
Publicado: (2021)

Advances in immune checkpoint inhibitors induced-cardiotoxicity
por: Li, Xiang, et al.
Publicado: (2023)

Cutaneous manifestations associated with immune checkpoint inhibitors
por: Watanabe, Tomoya, et al.
Publicado: (2023)

CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment
por: Han, Rui, et al.
Publicado: (2023)

The Versatility of Sirtuin-1 in Endocrinology and Immunology
por: Rasha, Fahmida, et al.
Publicado: (2020)

Evaluation of triple negative breast cancer with heterogeneous immune infiltration
por: Quintana, Ángela, et al.
Publicado: (2023)

Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
por: Zheng, Yiwen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nbhi9pj3mqup0pjltmrr39pb2e